共 231 条
[21]
Graetz N(2010)Weight change during chemotherapy changes the prognosis in non metastatic breast cancer for the worse BMC Cancer 10 648-47
[22]
Margono C(2013)Obesity and colorectal cancer Gut 62 933-34
[23]
Mullany EC(2014)Tumour expression of leptin is associated with chemotherapy resistance and therapy-independent prognosis in gastro-oesophageal adenocarcinomas Br J Cancer 110 1525-73
[24]
Biryukov S(2014)Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial Lancet Oncol 15 862-6
[25]
Abbafati C(2011)Phase III trial assessing bevacizumab in stages II and III carcinoma of the colon: results of NSABP protocol C-08 J Clin Oncol 29 11-33
[26]
Abera SF(2012)Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial Lancet Oncol 13 1225-93
[27]
Consultation WE(2012)Effect of oxaliplatin, fluorouracil, and leucovorin with or without cetuximab on survival among patients with resected stage III colon cancer: a randomized trial JAMA 307 1383-41
[28]
Kim CS(2006)Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803 J Clin Oncol 24 3535-70
[29]
Ko SH(2005)Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials J Clinical Oncol 23 8664-undefined
[30]
Kwon HS(undefined)undefined undefined undefined undefined-undefined